Bromfenac
Showing 1 - 25 of 67
Pain, Intravitreal Injection, Pain, Acute Trial in Canada, United States (Use of bromfenac 0.09% to reduce intravitreal
Recruiting
- Pain
- +2 more
- Use of bromfenac 0.09% to reduce intravitreal injection pain
- Use of artificial tears to reduce intravitreal injection pain
-
Boston, Massachusetts
- +4 more
Nov 8, 2023
Diabetic Macular Edema Trial (laser photocoagulation, eye drop bromfenac 0.09%, Placebo)
Completed
- Diabetic Macular Edema
- laser photocoagulation
- +2 more
- (no location specified)
Feb 10, 2023
Familial Exudative Vitreoretinopathies Trial (Bromfenac Sodium)
Not yet recruiting
- Familial Exudative Vitreoretinopathies
- Bromfenac Sodium
- (no location specified)
Oct 23, 2021
Cystoid Macular Edema Following Cataract Surgery Trial in Zagreb (Bromfenac Ophthalmic 0.09% Ophthalmic Solution, Dexamethasone
Completed
- Cystoid Macular Edema Following Cataract Surgery
- Bromfenac Ophthalmic 0.09% Ophthalmic Solution
- +3 more
-
Zagreb, Grad Zagreb, CroatiaKBCZagreb
May 15, 2022
Presbyopia Trial in Mexico City (Compound Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac, Pilocarpine
Recruiting
- Presbyopia
- Compound Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac
- +2 more
-
Mexico City, MexicoOptall Vision
Aug 14, 2021
Cataract Trial in Mount Pleasant (Pred-Gati-Brom, Prednisolone acetate 1% ophthalmic suspension, Gatifloxacin Ophthalmic)
Completed
- Cataract
- Pred-Gati-Brom
- +3 more
-
Mount Pleasant, South CarolinaCarolina Eyecare Physicians, LLC
Jun 9, 2022
Dry Eye Disease Trial (ISV 101)
Withdrawn
- Dry Eye Disease
- ISV 101
- (no location specified)
Nov 18, 2021
Presbyopia Trial in Mexico City (Pilocarpine, brimonidine, oxymetazoline, hyaluronic acid, bromfenac (PBOHB) compound)
Recruiting
- Presbyopia
- Pilocarpine, brimonidine, oxymetazoline, hyaluronic acid, bromfenac (PBOHB) compound
-
Mexico City, MexicoOptall Vision
Aug 14, 2021
Inflammation, Pseudophakia Trial (Bromfenac, Nepafenac)
Dry Eye Syndrome Trial in Irvine (Bromfenac Ophthalmic Solution A, Bromfenac Ophthalmic Solution B, Placebo Comparator)
Completed
- Dry Eye Syndrome
- Bromfenac Ophthalmic Solution A
- +2 more
-
Irvine, CaliforniaISTA Pharmaceuticals, Inc.
Sep 2, 2020
Glaucoma Trial (Bromfenac 0.07% Oph Susp, Dexamethasone)
Not yet recruiting
- Glaucoma
- Bromfenac 0.07% Oph Susp
- Dexamethasone
- (no location specified)
Oct 15, 2020
Macular Edema, Cystoid Macular Edema, Retinal Disease Trial in Worldwide (Bromfenac, Dexamethasone, Triamcinolone Acetonide)
Recruiting
- Macular Edema
- +5 more
- Bromfenac
- +3 more
-
Vienna, Austria
- +9 more
Dec 2, 2021
Dry Eye Disease Trial in Irvine (bromfenac ophthalmic solution 0.06%)
Completed
- Dry Eye Disease
- bromfenac ophthalmic solution 0.06%
-
Irvine, CaliforniaISTA Pharmaceuticals, Inc.
Aug 25, 2020
Intravitreal Injections, IVI Trial in Madison (Bromfenac, Artificial tears)
Completed
- Intravitreal Injections
- IVI
- Bromfenac
- Artificial tears
-
Madison, WisconsinUniversity of Wisconsin
Sep 24, 2020
Pterygium, Pain Trial in Guangzhou (0.1% bromfenac)
Completed
- Pterygium
- Pain
- 0.1% bromfenac
-
Guangzhou, Guangdong, China
- +1 more
Jul 13, 2019
Inflammation Eye Trial in Reggio Emilia (Bromfenac 0.09 % Ophthalmic Solution, Dexamethasone 0.1% ophthalmic suspension)
Completed
- Inflammation Eye
- Bromfenac 0.09 % Ophthalmic Solution
- Dexamethasone 0.1% ophthalmic suspension
-
Reggio Emilia, RE, ItalyArcispedale Santa Maria Nuova IRCSS - Ophthalmology
May 31, 2019
Pterygium, Ocular Pain, Ocular Inflammation Trial in Guadalajara, Ciudad de México (PRO-155, Placebo)
Inflammation, Cataract Trial in Guadalajara (Bromfenac)
Completed
- Inflammation
- Cataract
- Bromfenac
-
Guadalajara, Jalisco, MexicoUnidad Medica "Grupo Pediátrico"
Oct 2, 2019
Cataract Trial in Ciudad de Mexico (0,09% Bromfenac, 0,1% sodium hyaluronate)
Unknown status
- Cataract
- 0,09% Bromfenac
- 0,1% sodium hyaluronate
-
Ciudad de Mexico, MexicoMaria Camila Aguilar Sierra
Feb 4, 2019
Treatment of Ocular Inflammation Associated With Cataract Surgery Trial (Bromfenac, Nepafenac)
Completed
- Treatment of Ocular Inflammation Associated With Cataract Surgery
- Bromfenac
- Nepafenac
- (no location specified)
Mar 28, 2019
Ocular Inflammation Trial (ISV-303, DuraSite Vehicle)
Ocular Inflammation Trial (ISV-303, DuraSite Vehicle)
Cataract, Retinal Edema, Inflammation Trial in Nashville (Prolensa (bromfenac 0.07%), Ilevro (nepafenac 0.3%))
Completed
- Cataract
- +2 more
- Prolensa (bromfenac 0.07%)
- Ilevro (nepafenac 0.3%)
-
Nashville, TennesseeToyos Clinic
Oct 14, 2018